drugset / Trial / NCT01946620
A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Efficacy of Fluticasone/Formoterol in COPD Treatment. The Effect study.
Timeline
- Start
- 2013-10
- Primary completion
- 2016-04
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 125 ug | Inhaled |
| Subject | Fluticasone propionate | Other / unclassified | 250 ug | Inhaled |
| Comparator | Formoterol | Other / unclassified | 5 ug | Inhaled |
| Comparator | Formoterol | Other / unclassified | 10 ug | Inhaled |
| Comparator | Formoterol | Other / unclassified | 12 ug | Inhaled |